Company intelligence / Profile preview
HEC Pharm
- Ownership
- Private
- Development stage
- Commercial
Overview
HEC Pharm is a leading Chinese pharmaceutical company specializing in the manufacture of APIs and finished dosage forms. It became the largest manufacturer of oseltamivir in China after licensing from Roche in 2006 and played a key role during the H1N1 crisis by supplying nearly all national demand. The company also claims to be the world’s largest producer of macrolide antibiotics APIs and supplies global clients such as Pfizer and Abbott Laboratories. Its products are FDA & EDQM approved.
- Therapeutic areas
- PsychiatryEndocrinologyCardiovascularInfectious Diseases
- Modalities
- Small molecules (APIs and finished dosage forms)Macrolides antibiotics
- Industry
- Pharma
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on HEC Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HEC Pharm.